Emerging Drugs for Hypogonadism

    October 2006 in “ Expert Opinion on Emerging Drugs
    Daniel L. Edelstein, Adrian S. Dobs, Shehzad Basaria
    TLDR New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.
    The document reviewed emerging drugs for the treatment of hypogonadism as of 2006. It discussed various therapeutic options that were being developed to address the condition, which is characterized by low testosterone levels. The authors highlighted the potential benefits and mechanisms of action of these new drugs, as well as their clinical implications. The review emphasized the need for further research to establish the efficacy and safety of these treatments in larger populations, as the studies available at the time were limited in size and scope.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results
      Pharmacology of Anabolic Steroids

      research Pharmacology of Anabolic Steroids

      441 citations, May 2008 in “British Journal of Pharmacology”
      Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.
      Androgen Effects in Mammals

      research Androgen Effects in Mammals

      7 citations, January 2003 in “Elsevier eBooks”
      Testosterone is crucial for development, growth, and various body functions in mammals.
      What Is the Rationale for Androgen Therapy for Women?

      research What Is the Rationale for Androgen Therapy for Women?

      20 citations, January 2003 in “Treatments in Endocrinology”
      Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.